Q3 2026 13F filing
Updated 6 days ago266 disclosed positions worth $2.2B
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ABIVAX SA | $203.1M | 2.05M | 9.25% | — |
| 2 | S STATE STR SPDR S&P 500 ETF T | $135.5M | 177.6K | 6.17% | — |
| 3 | P PROTAGONIST THERAPEUTICS INC | $134M | 951.4K | 6.11% | — |
| 4 | R ROIVANT SCIENCES LTD | $112.6M | 3.08M | 5.13% | — |
| 5 | I IMMUNOVANT INC | $71.5M | 2.12M | 3.26% | — |
| 6 | D DENALI THERAPEUTICS INC | $42.8M | 2.07M | 1.95% | — |
| 7 | ? N/A EA SERIES TRUST | $39.9M | 337.1K | 1.82% | — |
| 8 | S SEPTERNA INC | $38.1M | 974.4K | 1.74% | — |
| 9 | M AGIOS PHARMACEUTICALS INC | $37.9M | 1.14M | 1.73% | — |
| 10 | A AURA BIOSCIENCES INC | $33.8M | 5.39M | 1.54% | — |
| 11 | V VIKING THERAPEUTICS INC | $33.7M | 1.03M | 1.54% | — |
| 12 | C CYTOKINETICS INC | $30.4M | 461.4K | 1.39% | — |
| 13 | I INSMED INC | $26.2M | 229.5K | 1.19% | — |
| 14 | F FREENOME INC | $25.9M | 1.65M | 1.18% | — |
| 15 | C CELLDEX THERAPEUTICS INC NEW | $25.9M | 799.3K | 1.18% | — |
| 16 | A ANTERIS TECHNOLOGIES GLOBAL | $25.2M | 3.24M | 1.15% | — |
| 17 | B BRIDGEBIO PHARMA INC | $25M | 379.3K | 1.14% | — |
| 18 | P PRAXIS PRECISION MEDICINES I | $24.7M | 84.8K | 1.12% | — |
| 19 | ? N/A FULCRUM THERAPEUTICS INC | $24.6M | 6.65M | 1.12% | — |
| 20 | V VIR BIOTECHNOLOGY INC | $24.1M | 2.16M | 1.10% | — |
| 21 | D DBV TECHNOLOGIES S A | $23.6M | 2.01M | 1.08% | — |
| 22 | E ENANTA PHARMACEUTICALS INC | $22.8M | 1.73M | 1.04% | — |
| 23 | E EDITAS MEDICINE INC | $22.8M | 8.89M | 1.04% | — |
| 24 | S SPYRE THERAPEUTICS INC | $21.2M | 237.6K | 0.96% | — |
| 25 | E ENLIVEN THERAPEUTICS INC | $20.3M | 442.7K | 0.92% | — |
| 26 | N NURIX THERAPEUTICS INC | $19.3M | 813.2K | 0.88% | — |
| 27 | S SANOFI SA | $19.2M | 464.6K | 0.87% | — |
| 28 | R REVOLUTION MEDICINES INC | $18M | 87.5K | 0.82% | — |
| 29 | S SAREPTA THERAPEUTICS INC | $17.3M | 952.1K | 0.79% | — |
| 30 | M MAZE THERAPEUTICS INC | $17.3M | 637.4K | 0.79% | — |
| 31 | A ADLAI NORTYE GROUP LTD | $16M | 997.4K | 0.73% | — |
| 32 | R RALLYBIO CORP | $15.9M | 926.4K | 0.73% | — |
| 33 | N NEKTAR THERAPEUTICS | $15.6M | 258.2K | 0.71% | — |
| 34 | U UROGEN PHARMA LTD | $15M | 369.8K | 0.68% | — |
| 35 | T TAYSHA GENE THERAPIES INC | $14.9M | 3.06M | 0.68% | — |
| 36 | M MONOPAR THERAPEUTICS INC | $14.3M | 179.0K | 0.65% | — |
| 37 | J JANUX THERAPEUTICS INC | $14.2M | 823.9K | 0.65% | — |
| 38 | R RHYTHM PHARMACEUTICALS INC | $13.2M | 138.7K | 0.60% | — |
| 39 | P PROTHENA CORP PLC | $12.8M | 1.52M | 0.58% | — |
| 40 | C COGENT BIOSCIENCES INC | $12.6M | 392.4K | 0.57% | — |
| 41 | R REGENERON PHARMACEUTICALS | $12.5M | 16.4K | 0.57% | — |
| 42 | S SPDR SERIES TRUST | $12.4M | 135.6K | 0.57% | — |
| 43 | T TENAX THERAPEUTICS INC | $12.3M | 6.52M | 0.56% | — |
| 44 | M MONTE ROSA THERAPEUTICS INC | $12M | 1.01M | 0.55% | — |
| 45 | A ABCELLERA BIOLOGICS INC | $12M | 822.2K | 0.55% | — |
| 46 | E ESTABLISHMENT LABS HLDGS INC | $11.9M | 185.6K | 0.54% | — |
| 47 | V VOGENX INC | $11.9M | 522.2K | 0.54% | — |
| 48 | I INHIBIKASE THERAPEUTICS INC | $11.7M | 5.71M | 0.53% | — |
| 49 | O OVID THERAPEUTICS INC | $11.4M | 4.56M | 0.52% | — |
| 50 | A AVALYN PHARMACEUTICALS INC | $11.3M | 397.7K | 0.52% | — |